Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dirk Schriefer, Rocco Haase, Nils-Henning Ness & Tjalf Ziemssen. (2022) Cost of illness in multiple sclerosis by disease characteristics – A review of reviews. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 177-195.
Read now
Read now
Peter Carney, Derek O’Boyle, Aidan Larkin, Christopher McGuigan & Killian O’Rourke. (2018) Societal costs of multiple sclerosis in Ireland. Journal of Medical Economics 21:5, pages 425-437.
Read now
Read now
Gabriel Adelman, Stanley G. Rane & Kathleen F. Villa. (2013) The cost burden of multiple sclerosis in the United States: a systematic review of the literature. Journal of Medical Economics 16:5, pages 639-647.
Read now
Read now
Norman J Kachuck. (2011) When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis. Neuropsychiatric Disease and Treatment 7, pages 197-208.
Read now
Read now
Articles from other publishers (16)
Jun Mi, Marie Ishida, Kanya Anindya, Barbara McPake, Bernadette Fitzgibbon, Anthony A. Laverty, An Tran-Duy & John Tayu Lee. (2023) Impact of health risk factors on healthcare resource utilization, work-related outcomes and health-related quality of life of Australians: a population-based longitudinal data analysis. Frontiers in Public Health 11.
Crossref
Crossref
Robert Simpson, Stephanie Posa, Tania Bruno, Sharon Simpson, Marina B. Wasilewski, Lawrence R. Robinson, Sarah Munce, Mark Bayley & Anthony Feinstein. (2022) Conceptualization, use, and outcomes associated with compassion in the care of people with multiple sclerosis: a scoping review. Journal of Neurology 270:3, pages 1300-1322.
Crossref
Crossref
Robert Simpson, Stephanie Posa, Laura Langer, Tania Bruno, Sharon Simpson, Maggie Lawrence, Jo Booth, Stewart W. Mercer, Anthony Feinstein & Mark Bayley. (2022) A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis. Journal of Neurology 270:2, pages 726-745.
Crossref
Crossref
Thomas G. Poder, Lucien P. Coulibaly, Myriam Gaudreault, Simon Berthelot & Maude Laberge. (2021) Validated Tools to Measure Costs for Patients: A Systematic Review. The Patient - Patient-Centered Outcomes Research 15:1, pages 3-19.
Crossref
Crossref
Jalal Dahham, Rana Rizk, Ingrid Kremer, Silvia M. A. A. Evers & Mickaël Hiligsmann. (2021) Economic Burden of Multiple Sclerosis in Low- and Middle‐Income Countries: A Systematic Review. PharmacoEconomics 39:7, pages 789-807.
Crossref
Crossref
Nils-Henning Ness, Rocco Haase, Raimar Kern, Dirk Schriefer, Benjamin Ettle, Christian Cornelissen, Katja Akguen & Tjalf Ziemssen. (2020) The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study. Journal of Medical Internet Research 22:3, pages e17921.
Crossref
Crossref
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Emilie Friberg, Jan Hillert & Petter Tinghög. (2017) Comparing costs of illness of multiple sclerosis in three different years: A population-based study. Multiple Sclerosis Journal 24:4, pages 520-528.
Crossref
Crossref
Hanna Gyllensten, Michael Wiberg, Kristina Alexanderson, Anders Norlund, Emilie Friberg, Jan Hillert, Olivia Ernstsson & Petter Tinghög. (2017) Costs of illness of multiple sclerosis in Sweden: a population-based register study of people of working age. The European Journal of Health Economics 19:3, pages 435-446.
Crossref
Crossref
H. JIANG, S. HUANG, Y. ZHAO, Y. WANG, C. YANG, J. CAI, Z. WANG, J. ZHANG, X. ZHANG & H. JIN. (2017) Disease burden of hepatitis E in a rural population in China: a community-based survey. Epidemiology and Infection 145:5, pages 908-913.
Crossref
Crossref
Olivia Ernstsson, Hanna Gyllensten, Kristina Alexanderson, Petter Tinghög, Emilie Friberg & Anders Norlund. (2016) Cost of Illness of Multiple Sclerosis - A Systematic Review. PLOS ONE 11:7, pages e0159129.
Crossref
Crossref
Arnaud Kwiatkowski, Jean-Pierre Marissal, Madani Pouyfaucon, Patrick Vermersch, Patrick Hautecoeur & Benoît Dervaux. (2014) Social participation in patients with multiple sclerosis: correlations between disability and economic burden. BMC Neurology 14:1.
Crossref
Crossref
Uwe K. Zettl, Thomas Henze, Ute Essner & Peter Flachenecker. (2013) Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I). The European Journal of Health Economics 15:9, pages 953-966.
Crossref
Crossref
Jonathan D. Campbell, Vahram Ghushchyan, R. Brett McQueen, Sharon Cahoon-Metzger, Terrie Livingston, Timothy Vollmer, John Corboy, Augusto Miravalle, Teri Schreiner, Victoria Porter & Kavita Nair. (2014) Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Multiple Sclerosis and Related Disorders 3:2, pages 227-236.
Crossref
Crossref
Shaloo Gupta, Amir Goren, Amy L Phillips, Fernando Dangond & Michelle Stewart. (2014) Self-reported severity among patients with multiple sclerosis in the U.S. and its association with health outcomes. Multiple Sclerosis and Related Disorders 3:1, pages 78-88.
Crossref
Crossref
Hiromi Kikuchi, Nobuhiro Mifune, Masaaki Niino, Jun-ichi Kira, Tatsuo Kohriyama, Kohei Ota, Masami Tanaka, Hirofumi Ochi, Shunya Nakane & Seiji Kikuchi. (2013) Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis. BMC Neurology 13:1.
Crossref
Crossref
Alan M. Palmer. (2012) Pharmacotherapeuetic Options for the Treatment of Multiple Sclerosis. Clinical Medicine Insights: Therapeutics 4, pages CMT.S8661.
Crossref
Crossref